Company intelligence / Profile preview

Mycopunks

Leeds, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Mycopunks is a UK-based biotechnology company specializing in the cultivation and processing of functional mushrooms for health and wellness applications. The company focuses on providing high-quality, UK-grown mushroom extracts and grow kits, emphasizing sustainable and local production methods. Their product line includes supplements derived from species such as Lion's Mane, Reishi, and Cordyceps, aimed at improving cognitive function and immune health. Mycopunks also provides educational resources and equipment for home cultivation, fostering a community around mycology and sustainable food systems.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Fungi-based productsNutraceuticals
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Mycopunks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycopunks.

Explore the full profile